A detailed history of Fil LTD transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Fil LTD holds 573,600 shares of CTKB stock, worth $3.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
573,600
Previous 573,600 -0.0%
Holding current value
$3.71 Million
Previous $3.2 Million 0.72%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$6.69 - $11.99 $13,065 - $23,416
-1,953 Reduced 0.34%
573,600 $4.9 Million
Q1 2023

May 11, 2023

SELL
$8.44 - $13.47 $65,907 - $105,187
-7,809 Reduced 1.34%
575,553 $5.29 Million
Q1 2022

May 13, 2022

SELL
$9.89 - $17.25 $20.6 Million - $35.9 Million
-2,083,238 Reduced 78.12%
583,362 $6.29 Million
Q3 2021

Nov 15, 2021

BUY
$17.52 - $27.93 $46.7 Million - $74.5 Million
2,666,600 New
2,666,600 $57.1 Million

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $870M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.